About: Raffaele Scarpa

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Raffaele Scarpa Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) дослідник (uk) باحت (ary) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Raffaele Scarpa (en) Raffaele Scarpa (es) Raffaele Scarpa (it) Raffaele Scarpa (nl) Raffaele Scarpa (ast)
skos:prefLabel	Raffaele Scarpa (en) Raffaele Scarpa (es) Raffaele Scarpa (it) Raffaele Scarpa (nl) Raffaele Scarpa (ast)
name	Raffaele Scarpa (en) Raffaele Scarpa (es) Raffaele Scarpa (it) Raffaele Scarpa (nl) Raffaele Scarpa (ast)
Scopus author ID	wds:Q57047962-16478E80-4CE7-452B-9D33-C34C9FF16426
Scopus author ID	7101679872
given name	wds:Q57047962-37C6CCC7-1B24-4475-B2BC-7213D52B6C16
given name	Raffaele
instance of	wds:Q57047962-6311EC9E-2036-4048-8B89-6197F0604B96
instance of	Homo sapiens
occupation	wds:Q57047962-8B8C3DD2-FFC5-4FA3-9CE5-ACA002688F4A
sex or gender	wds:Q57047962-244882F2-B6BE-4F94-B705-12003C83CA4F
on focus list of Wikimedia project	wds:Q57047962-2D6CFF27-70EE-4402-A07D-67F906318440
family name	wds:Q57047962-86EF9971-29BD-4D9D-AAFE-A22A62382F16
occupation	researcher
sex or gender	male
on focus list of Wikimedia project	WikiProject COVID-19
family name	Scarpa
ORCID iD	wds:Q57047962-B452ED56-28B3-47BB-999D-C5E33C0C32B1
ORCID iD	https://orcid.org/0000-0002-5808-6607
ORCID iD	0000-0002-5808-6607
IRIS UNINA author ID	wds:Q57047962-9FE756E3-BF3E-434E-A0AA-9C716D9F4F6F
IRIS UNINA author ID	19739
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57047962
is author of	The arthritis of ulcerative colitis: clinical and genetic aspects Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) Nail and distal interphalangeal joint in psoriatic arthritis. Dynamic contrast-enhanced magnetic resonance imaging of articular and extraarticular synovial structures of the hands in patients with psoriatic arthritis. The acromegalic arthropathy. Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Osteoarthritis: an overview of the disease and its treatment strategies. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers Dactylitis or "sausage-shaped" digit Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms Psoriasis, psoriatic arthritis, or psoriatic disease? The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. New Developments in Magnetic Resonance Imaging of the Nail Unit Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis Platelet reactivity and disease activity in subjects with psoriatic arthritis Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study Enteropathic spondyloarthritis: from diagnosis to treatment. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease Biological therapies for spondyloarthritis Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease. Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor- Blockers for Psoriatic Arthritis Magnetic Resonance Imaging of Nail Unit in Psoriatic Arthritis Cigarette Smoking and Appendectomy are Risk Factors for Extraintestinal Manifestations in Ulcerative Colitis Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis Discovertebral erosions in patients with enteropathic spondyloarthritis Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study Emerging drugs for psoriatic arthritis Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis Early psoriatic arthritis: the clinical spectrum Efficacy of tocilizumab in a patient with refractory psoriatic arthritis Osteoporosis and psoriatic arthritis. Managing moderate-to-severe psoriasis in the elderly Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Measuring psoriatic disease in clinical practice. An expert opinion position paper. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software